PCR and Antibody Diagnostic Kits

Introduction

Ndiyo Biosciences Limited is pioneering a game-changing biotechnology initiative aimed at transforming Uganda’s healthcare and agricultural diagnostic landscape. The PCR and Antibody Diagnostic Kits Project seeks to establish a state-of-the-art factory that will locally manufacture diagnostic kits for human, veterinary, and plant diseases. By doing so, the project will significantly reduce Uganda’s dependence on imported diagnostics, improve disease detection capabilities, and foster economic growth through biotechnology.

With Uganda and the broader Sub-Saharan Africa region facing a high burden of infectious and non-communicable diseases, this project is designed to provide affordable, reliable, and accessible diagnostic solutions for conditions such as HIV, malaria, tuberculosis, COVID-19, and various plant and livestock diseases.

Project Overview

The PCR and Antibody Diagnostic Kits Project is a five-year initiative that will position Uganda as a leader in biotechnology manufacturing. The project focuses on:

Constructing a Good Manufacturing Practices (GMP)-compliant facility for diagnostic kit production.
Scaling up the production of recombinant antibodies and enzymes needed for diagnostic and research kits.
Producing PCR and antibody diagnostic kits for a range of diseases affecting humans, animals, and plants.
Strengthening Uganda’s position in the pathogen economy by creating a sustainable local industry.

Through this initiative, Uganda will be able to locally produce high-quality diagnostic kits that meet international standards, reduce healthcare costs, and increase access to rapid and accurate disease detection tools.

Investigators

Prof. Moses Lutaakome Joloba

Principal Investigator

Bio

Dr. Bagaya Sentalo Bernard

Co-Investigator

Bio

Assoc. Prof. David Patrick Kateete

Co-Investigator

BIo

Key Objectives:

The primary goal of the project is to enhance Uganda’s capacity for biotechnology manufacturing. The specific objectives include:

Establish a State-of-the-Art PCR and Antibody Diagnostic Kit Factory

Production lines for oligonucleotide synthesis, enzyme production, and peptide synthesis.
Cold storage rooms to preserve diagnostic reagents.
Quality assurance and validation laboratories to ensure compliance with regulatory standards.
Administrative and training facilities to support research and workforce development.

Scale Up Capacity for Recombinant Antibody and Enzyme Production

Produce highly purified enzymes and antibodies for research and diagnostics.
Support local and international markets by providing affordable diagnostic reagents.
Reduce reliance on imported laboratory supplies, making diagnostics more accessible.

Develop and Commercialize PCR and Antibody Diagnostic Kits

The project will focus on manufacturing PCR-based diagnostic kits for diseases such as:

COVID-19
HIV/AIDS
Tuberculosis (TB)
Malaria
Agricultural diseases like tomato wilt virus and East Coast Fever in livestock

Project Implementation Plan

The project will be executed in four key phases over five years:

Phase 1: Facility Construction & Setup

Build a GMP-compliant diagnostic kit factory with cutting-edge production lines.
Procure specialized equipment for oligonucleotide, enzyme, and antibody synthesis.
Work with regulatory bodies like NDA, UNBS, and WHO to certify the facility.

Phase 2: Capacity Building & Production Scale-Up

Train local scientists in biotechnology manufacturing and quality control.
Develop a production pipeline for PCR and antibody-based diagnostic kits.
Establish a supply chain for raw materials and reagents.

Phase 3: Product Development & Commercialization

Brand, package, and market locally produced diagnostic kits.
Partner with hospitals, research institutions, and international distributors to expand market reach.
Obtain regulatory approvals for local and export markets.

Phase 4: Market Expansion & Sustainability

Establish Uganda’s first pathogen park, attracting more biotechnology investors.
Expand manufacturing capacity to include additional diagnostic products.
Strengthen collaborations with government agencies and private sector partners.

Why This Matters for Uganda’s Healthcare & Economy

Reducing the Cost of Diagnostics

Uganda spends millions of dollars annually on imported diagnostic kits. For example:

In 2019, Uganda conducted 1.46 million HIV tests, costing $160.6 million.
Since March 2020, over 2.5 million COVID-19 tests have been conducted at a cost of $92.5 million.

By locally producing diagnostic kits, Uganda can cut costs significantly and reinvest savings into healthcare infrastructure.

Creating Jobs and Strengthening Uganda’s Biotechnology Industry

The project will generate employment opportunities for scientists, engineers, and professionals in biotechnology and related fields. It will also foster technology transfer and skill development for future generations.

Enhancing Disease Preparedness

The COVID-19 pandemic exposed the vulnerability of Uganda’s healthcare system due to its dependence on imported diagnostics. Establishing local manufacturing will ensure faster response times during future epidemics and pandemics.

Supporting Agricultural and Veterinary Sectors

By producing diagnostic kits for crop and livestock diseases, this project will support Ugandan farmers and veterinarians, helping them detect and manage diseases more efficiently.